$13.96
Value $474M
IPX and LIN stock compared: price, dividend, valuation and results, from SEC filings.
$13.96
Value $474M
$526.06
Value $244B
IperionX (IPX) has a market value of $474M and Linde (LIN) $244B. Over the last year, with dividends, IPX moved -59.1% and LIN +24.3%. Dividend yield: IPX none, LIN 1.20%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
IPX$474M
LIN$244B
LIN is 515 times IPX
Revenue, 12 months
IPX–
LIN$36.2B
Net income, 12 months
IPX-$67M
LIN$7.0B
Operating margin
IPX–
LIN25.3%
ROIC
IPX-57.1%
LIN11.1%
68.1 points apart
P/E
IPX–
LIN34.8
Dividend yield
IPX0.0%
LIN1.2%
1.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
IPX+41.7%
LIN+36.7%
| Period | IPXWith dividends | LINWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | -59.1%Price -59.1% | +24.3%Price +22.6% |
| 3 years since November 13, 2023 | +41.7%+12.3% a yearPrice +41.7% | +36.7%+11.0% a yearPrice +31.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
IPXIperionXLINLinde
| Price | $13.96 | $526.06 |
|---|---|---|
| Market value | $474M | $244B |
| Enterprise value (EV) | – | $265B |
| P/E | – | 34.8 |
| P/E, 5-year median | – | 32.6 |
| P/B | 5.4 | 6.2 |
| EV/EBIT | – | 28.9 |
| Free cash flow yield | – | 2.1% |
| Revenue, 12 months | – | $36.2B |
|---|---|---|
| Net income, 12 months | -$67M | $7.0B |
| Free cash flow, 12 months | -$63M | $5.1B |
| Earnings per share, 12 months | -$2.00 | $15.06 |
| Revenue growth, year on year | – | 3.0% |
| Revenue growth a year, past | – | +4.5%over 5 years |
| EPS growth a year, past | – | +25.4%over 5 years |
| Gross margin | – | 47.9% |
|---|---|---|
| Operating margin | – | 25.3% |
| Net margin | – | 19.3% |
| ROIC | -57.1% | 11.1% |
| ROE | -75.6% | 18.1% |
| Cash | $35M | $3.9B |
|---|---|---|
| Total debt | – | $25.2B |
| Net debt / EBITDA | – | 1.7 |
| Interest cover | -19.3× | 35.5× |
| Dividend yield | – | 1.2% |
|---|---|---|
| Dividend per share, 12 months | – | $6.30 |
| Dividend growth a year, past | – | +9.3%over 5 years |
| Buyback yield | – | 1.9% |
| Shareholder yield | – | 3.1% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Linde ($244B) is about 514.5 times IperionX ($474M), at today's prices.
Since November 13, 2023, IPX's price moved +41.7% and LIN's +31.6%. With dividends: IPX +41.7% (+12.3% a year), LIN +36.7% (+11.0% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for IperionX and 1.20% for Linde. Over the last twelve months they paid – and $6.30 per share.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.